4,070 Shares in GE HealthCare Technologies Inc. $GEHC Purchased by MBB Public Markets I LLC

Key Points

• MBB Public Markets I LLC has made a new investment of approximately <$328,000> in GE HealthCare Technologies by acquiring 4,070 shares during the first quarter.
• GE HealthCare Technologies reported earnings per share of $1.06 for the last quarter, exceeding the consensus estimate of $0.91, with a revenue of $5 billion.
• The company has announced a quarterly dividend of $0.035 per share, representing an annualized yield of 0.2%.

MBB Public Markets I LLC bought a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,070 shares of the company's stock, valued at approximately $328,000.

Other large investors have also added to or reduced their stakes in the company. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies during the first quarter worth $25,000. Bogart Wealth LLC boosted its holdings in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after purchasing an additional 247 shares during the last quarter. Stonebridge Financial Group LLC boosted its holdings in GE HealthCare Technologies by 165.7% during the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after purchasing an additional 222 shares during the last quarter. Ameriflex Group Inc. acquired a new position in GE HealthCare Technologies during the fourth quarter worth $31,000. Finally, Olde Wealth Management LLC acquired a new position in GE HealthCare Technologies during the first quarter worth $35,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC traded up $1.97 during mid-day trading on Thursday, reaching $77.96. 4,355,639 shares of the company were exchanged, compared to its average volume of 2,891,212. The company's 50-day simple moving average is $74.45 and its 200-day simple moving average is $73.76. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. The stock has a market capitalization of $35.59 billion, a P/E ratio of 15.98, a P/E/G ratio of 2.90 and a beta of 1.13. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. The company had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. GE HealthCare Technologies's quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter last year, the company posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

Wall Street Analyst Weigh In

Several brokerages recently commented on GEHC. Citigroup increased their target price on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a report on Thursday, July 31st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research note on Saturday, May 31st. Finally, Morgan Stanley cut their price target on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the company. According to MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and a consensus target price of $88.40.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.